Hautarztpraxis Dr. Niesmann and Dr. Othlinghaus | Hautzentrum im Jahrhunderthaus

Research site
Alleestr. 80, Bochum, North Rhine-Westphalia, Germany
Site insights

Top conditions

Psoriasis (2 trials)

Eczema (2 trials)

Dermatitis (2 trials)

Atopic Dermatitis (2 trials)

Top treatments

ABP 654
ABP 501

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


1 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.

Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab

Trial sponsors

Amgen logo

Amgen (2 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems